Crosstalk between steroid receptors and the c-Src-receptor tyrosine kinase pathways: implications for cell proliferation

被引:159
作者
Shupnik, MA [1 ]
机构
[1] Univ Virginia, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Charlottesville, VA 22908 USA
关键词
estrogen receptor; progesterone receptor; IGF-1; receptor; EGF-receptor; transcription; cell proliferation;
D O I
10.1038/sj.onc.1208076
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Both steroids and growth factors stimulate proliferation of steroid-dependent tumor cells, and interaction between these signaling pathways may occur at several levels. Steroid receptors are typically classified as ligand-activated transcription factors, and steps by which they bind ligand, dimerize, recruit coregulatory molecules, and activate target gene transcription are well understood. Several steroid responses are functionally linked to c-Src or tyrosine kinase receptors, and the physiological impact and the precise molecular pathways involved in these responses are under intensive investigation. Ligand-independent stimulation of steroid receptor-mediated transcription by growth factors is now believed to occur through activated protein kinases that phosphorylate the receptors and receptor coregulators. Recently, steroid hormones themselves have been shown to rapidly activate intracellular signaling cascades, via binding to cognate cytoplasmic or membrane-associated receptors. In some contexts, steroid receptors interact directly with c-Src and other cytoplasmic signaling molecules, such as Shc, PI3K, and p130 Cas. Crosstalk between growth factors and steroids in both the cytoplasm and nucleus could have profound impact on complex biological processes such as cell growth, and play a significant role in the treatment of steroid-dependent cancers. The potential roles of progesterone and estrogen receptors in this crosstalk are discussed in this review.
引用
收藏
页码:7979 / 7989
页数:11
相关论文
共 127 条
[1]   Insulin-like growth factor 1 is required for G2 progression in the estradiol-induced mitotic cycle [J].
Adesanya, OO ;
Zhou, J ;
Samathanam, C ;
Powell-Braxton, L ;
Bondy, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (06) :3287-3291
[2]   G protein-coupled receptor 30 is critical for a progestin-induced growth inhibition in MCF-7 breast cancer cells [J].
Ahola, TM ;
Manninen, T ;
Alkio, N ;
Ylikomi, T .
ENDOCRINOLOGY, 2002, 143 (09) :3376-3384
[3]  
Ankrapp DP, 1998, J CELL PHYSIOL, V174, P251, DOI 10.1002/(SICI)1097-4652(199802)174:2<251::AID-JCP12>3.0.CO
[4]  
2-F
[5]   PHOSPHORYLATION OF THE HUMAN ESTROGEN-RECEPTOR ON TYROSINE-537 IN-VIVO AND BY SRC FAMILY TYROSINE KINASES IN-VITRO [J].
ARNOLD, SF ;
OBOURN, JD ;
JAFFE, H ;
NOTIDES, AC .
MOLECULAR ENDOCRINOLOGY, 1995, 9 (01) :24-33
[6]   Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells [J].
Ballaré, C ;
Uhrig, M ;
Bechtold, T ;
Sancho, E ;
Di Domenico, M ;
Migliaccio, A ;
Auricchio, F ;
Beato, M .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (06) :1994-2008
[7]   Modulation of AP-1 activity by the human progesterone receptor in endometrial adenocarcinoma cells [J].
Bamberger, AM ;
Bamberger, CM ;
Gellersen, B ;
Schulte, HM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) :6169-6174
[8]   Characterization of the interactions of estrogen receptor and MNAR in the activation of cSrc [J].
Barletta, F ;
Wong, CW ;
McNally, C ;
Komm, BS ;
Katzenellenbogen, B ;
Cheskis, BJ .
MOLECULAR ENDOCRINOLOGY, 2004, 18 (05) :1096-1108
[9]   GENE-REGULATION BY STEROID-HORMONES [J].
BEATO, M .
CELL, 1989, 56 (03) :335-344
[10]   c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function [J].
Biscardi, JS ;
Maa, MC ;
Tice, DA ;
Cox, ME ;
Leu, TH ;
Parsons, SJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (12) :8335-8343